Axogen Inc Financials
Axogen Inc (AXGN) reported $225.2M in revenue for fiscal year 2025, up 20.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Axogen’s high-gross-margin model is nearing operating self-funding, but inventory needs and financing costs still absorb much of the scaling benefit.
Between FY2023 and FY2025, long-term debt barely moved. Yet interest expense reached$7.7M while debt was only$48.4M , so recent net losses reflect a pricier balance sheet more than a bigger one.
Revenue scale has pushed the business close to cash breakeven: operating cash flow was
The balance sheet looks liquid in the short term, with a current ratio of 5.1x and cash of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Axogen Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Axogen Inc has an operating margin of -3.5%, meaning the company loses $3 on every $100 of revenue. This results in a profitability score of 34/100. This is down from -1.8% the prior year.
Axogen Inc's revenue surged 20.2% year-over-year to $225.2M, reflecting rapid business expansion. This strong growth earns a score of 81/100.
Axogen Inc carries a low D/E ratio of 0.38, meaning only $0.38 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 65/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 5.11, Axogen Inc holds $5.11 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 90/100.
While Axogen Inc generated $812K in operating cash flow, capex of $3.7M consumed most of it, leaving -$2.9M in free cash flow. This results in a low score of 23/100, reflecting heavy capital investment rather than weak cash generation.
Axogen Inc posts a -12.2% return on equity (ROE), meaning it loses $12 for every $100 of shareholders' equity. This results in a returns score of 33/100. This is down from -9.6% the prior year.
Axogen Inc scores 17.41, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.8B) relative to total liabilities ($92.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Axogen Inc passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Axogen Inc reported a net loss of $15.7M while generating $812K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Axogen Inc reported an operating loss of $7.8M against $7.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Axogen Inc generated $225.2M in revenue in fiscal year 2025. This represents an increase of 20.2% from the prior year.
Axogen Inc's EBITDA was -$1.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 137.4% from the prior year.
Axogen Inc reported -$15.7M in net income in fiscal year 2025. This represents a decrease of 57.6% from the prior year.
Axogen Inc earned -$0.34 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 47.8% from the prior year.
Cash & Balance Sheet
Axogen Inc recorded an outflow of $2.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 304.5% from the prior year.
Axogen Inc held $35.5M in cash against $48.4M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Axogen Inc's gross margin was 74.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the prior year.
Axogen Inc's operating margin was -3.5% in fiscal year 2025, reflecting core business profitability. This is down 1.7 percentage points from the prior year.
Axogen Inc's net profit margin was -7.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.7 percentage points from the prior year.
Axogen Inc's ROE was -12.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.6 percentage points from the prior year.
Capital Allocation
Axogen Inc invested $32.9M in research and development in fiscal year 2025. This represents an increase of 18.4% from the prior year.
Axogen Inc invested $3.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 20.8% from the prior year.
Not reported for fiscal year 2025.
AXGN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $251.2M | $225.2M+20.2% | $187.3M+17.8% | $159.0M+14.7% | $138.6M+8.8% | $127.4M+13.4% | $112.3M+5.2% | $106.7M+27.1% | $83.9M+38.9% | $60.4M+47.0% | $41.1M+50.4% | $27.3M+62.5% | $16.8M+53.6% | $10.9M+42.3% | $7.7M+58.6% | $4.8M |
| Cost of Revenue | $63.9M | $57.9M+27.5% | $45.4M+22.1% | $37.1M+24.7% | $29.8M+29.8% | $22.9M+6.3% | $21.6M+24.4% | $17.3M+34.2% | $12.9M+38.8% | $9.3M+44.0% | $6.5M+33.4% | $4.8M+40.9% | $3.4M+41.1% | $2.4M+24.4% | $2.0M-19.1% | $2.4M |
| Gross Profit | $187.3M | $167.4M+17.9% | $142.0M+16.5% | $121.9M+12.0% | $108.8M+4.2% | $104.4M+15.1% | $90.7M+1.5% | $89.4M+25.8% | $71.0M+38.9% | $51.1M+47.6% | $34.6M+54.1% | $22.5M+68.1% | $13.4M+57.2% | $8.5M+48.5% | $5.7M+136.5% | $2.4M |
| R&D Expenses | $36.0M | $32.9M+18.4% | $27.8M+1.6% | $27.3M+6.7% | $25.6M+6.0% | $24.2M+35.5% | $17.8M+1.9% | $17.5M+48.8% | $11.8M+75.7% | $6.7M+59.0% | $4.2M+30.1% | $3.2M+6.7% | $3.0M+42.7% | $2.1M+48.9% | $1.4M+104.7% | $697K |
| SG&A Expenses | $51.7M | $44.6M+14.2% | $39.0M+1.6% | $38.4M-6.1% | $40.9M+26.5% | $32.3M+22.5% | $26.4M-15.7% | $31.3M+35.4% | $23.1M+57.0% | $14.7M+45.4% | $10.1M+20.3% | $8.4M+21.2% | $6.9M+21.6% | $5.7M+9.5% | $5.2M+21.0% | $4.3M |
| Operating Income | -$12.8M | -$7.8M-138.8% | -$3.3M+84.7% | -$21.5M+27.8% | -$29.7M-16.9% | -$25.4M-9.6% | -$23.2M+26.2% | -$31.4M-53.2% | -$20.5M-157.8% | -$8.0M+2.2% | -$8.1M+12.3% | -$9.3M+5.4% | -$9.8M-2.2% | -$9.6M-22.9% | -$7.8M-12.0% | -$7.0M |
| Interest Expense | $4.2M | $7.7M-6.1% | $8.2M+189.5% | $2.8M+354.3% | $624K-54.0% | $1.4M+28.7% | $1.1M+2535.0% | $40K-96.7% | $1.2M-45.5% | $2.2M-58.8% | $5.4M+35.0% | $4.0M-41.4% | $6.8M+41.3% | $4.8M+246.4% | $1.4M+27.1% | $1.1M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0+100.0% | -$738K | N/A |
| Net Income | -$33.5M | -$15.7M-57.6% | -$10.0M+54.1% | -$21.7M+25.0% | -$28.9M-7.3% | -$27.0M-13.4% | -$23.8M+18.4% | -$29.1M-30.1% | -$22.4M-114.4% | -$10.4M+27.5% | -$14.4M-7.9% | -$13.4M+24.6% | -$17.7M-21.7% | -$14.6M-54.6% | -$9.4M-2.2% | -$9.2M |
| EPS (Diluted) | — | -$0.34-47.8% | -$0.23+54.9% | -$0.51+26.1% | -$0.69-6.2% | -$0.65-8.3% | -$0.60+18.9% | -$0.74 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AXGN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $221.7M+8.8% | $203.7M+3.5% | $196.8M+0.7% | $195.4M-6.1% | $208.0M+3.3% | $201.4M+30.2% | $154.6M-3.5% | $160.2M+172.1% | $58.9M+27.0% | $46.4M+26.3% | $36.7M+123.8% | $16.4M-40.8% | $27.7M+36.8% | $20.2M+61.9% | $12.5M |
| Current Assets | $120.4M+21.4% | $99.2M+12.7% | $88.0M-10.3% | $98.1M-22.8% | $127.0M-12.5% | $145.3M+7.6% | $135.0M-10.6% | $151.0M+170.8% | $55.7M+26.6% | $44.0M+25.6% | $35.1M+143.2% | $14.4M-43.8% | $25.7M+40.2% | $18.3M+68.1% | $10.9M |
| Cash & Equivalents | $35.5M+29.0% | $27.6M-11.2% | $31.0M+103.0% | $15.3M-53.3% | $32.8M-32.8% | $48.8M+36.5% | $35.7M+47.0% | $24.3M-33.5% | $36.5M+21.6% | $30.0M+15.8% | $25.9M+215.4% | $8.2M-59.1% | $20.1M+44.3% | $13.9M+69.8% | $8.2M |
| Inventory | $42.4M+27.7% | $33.2M+44.1% | $23.0M+21.8% | $18.9M+13.3% | $16.7M+33.2% | $12.5M-9.6% | $13.9M+15.7% | $12.0M+63.8% | $7.3M+34.0% | $5.5M+38.8% | $3.9M+22.4% | $3.2M-5.4% | $3.4M+7.8% | $3.2M+79.0% | $1.8M |
| Accounts Receivable | $26.2M+8.6% | $24.1M-4.1% | $25.1M+13.3% | $22.2M+22.2% | $18.2M+3.1% | $17.6M+4.0% | $16.9M+10.6% | $15.3M+38.5% | $11.1M+37.4% | $8.1M+68.4% | $4.8M+66.5% | $2.9M+51.7% | $1.9M+80.3% | $1.1M+31.6% | $798K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $170K |
| Total Liabilities | $92.8M-7.0% | $99.8M-1.3% | $101.2M+7.2% | $94.4M-1.1% | $95.5M+22.0% | $78.2M+247.9% | $22.5M+70.5% | $13.2M-60.8% | $33.7M+7.2% | $31.4M+10.3% | $28.5M+3.1% | $27.6M+0.4% | $27.5M+19.5% | $23.1M+259.0% | $6.4M |
| Current Liabilities | $23.6M-23.0% | $30.6M+0.6% | $30.4M+28.1% | $23.8M-2.2% | $24.3M+6.4% | $22.8M+9.3% | $20.9M+60.1% | $13.0M-4.9% | $13.7M+23.8% | $11.1M+198.7% | $3.7M+51.7% | $2.4M+16.6% | $2.1M+41.8% | $1.5M-26.7% | $2.0M |
| Long-Term Debt | $48.4M+1.9% | $47.5M+1.9% | $46.6M+1.9% | $45.7M+2.0% | $44.8M+39.9% | $32.0M | $0-100.0% | $35K-99.8% | $19.8M-2.2% | $20.3M-18.0% | $24.7M-1.5% | $25.1M-1.1% | $25.4M+17.5% | $21.6M+390.0% | $4.4M |
| Total Equity | $128.8M+24.0% | $103.9M+8.6% | $95.7M-5.3% | $101.0M-10.3% | $112.5M-8.6% | $123.1M-6.8% | $132.2M-10.1% | $147.0M+483.7% | $25.2M+68.8% | $14.9M+82.1% | $8.2M+172.9% | -$11.2M-8330.6% | $137K+104.8% | -$2.8M-146.6% | $6.1M |
| Retained Earnings | -$307.0M-5.4% | -$291.3M-3.5% | -$281.3M-8.4% | -$259.6M-12.6% | -$230.6M-13.3% | -$203.6M-13.2% | -$179.9M-19.3% | -$150.7M-17.5% | -$128.3M-8.9% | -$117.9M-13.9% | -$103.5M-14.8% | -$90.1M-24.5% | -$72.4M-25.2% | -$57.8M-19.4% | -$48.4M |
AXGN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $15.0M | $812K-82.1% | $4.5M+179.3% | -$5.7M+64.4% | -$16.1M-19.9% | -$13.4M-39.3% | -$9.6M+51.6% | -$19.9M-11.3% | -$17.9M-93.4% | -$9.2M+17.8% | -$11.2M+13.9% | -$13.1M-24.9% | -$10.5M-0.1% | -$10.4M-20.6% | -$8.7M-22.4% | -$7.1M |
| Capital Expenditures | $6.4M | $3.7M+20.8% | $3.1M-77.6% | $13.9M-30.9% | $20.1M-27.8% | $27.8M+27.0% | $21.9M+369.7% | $4.7M-25.8% | $6.3M+468.5% | $1.1M+18.7% | $931K+127.7% | $409K-24.6% | $542K+203.2% | $179K+268.9% | $48K+135.1% | $21K |
| Free Cash Flow | $8.6M | -$2.9M-304.5% | $1.4M+107.3% | -$19.6M+45.8% | -$36.1M+12.3% | -$41.2M-30.7% | -$31.5M-28.5% | -$24.5M-1.6% | -$24.1M-133.4% | -$10.3M+15.0% | -$12.2M+9.6% | -$13.5M-22.4% | -$11.0M-3.5% | -$10.6M-22.0% | -$8.7M-22.7% | -$7.1M |
| Investing Cash Flow | -$15.2M | -$5.3M+48.4% | -$10.3M-153.5% | $19.3M+701.7% | -$3.2M+86.5% | -$23.6M-39.4% | -$17.0M-162.2% | $27.3M+127.8% | -$98.2M-7500.1% | -$1.3M-11.7% | -$1.2M-108.3% | -$556K | N/A | N/A | -$127K-101.8% | $7.1M |
| Financing Cash Flow | $70.7M | $10.5M+358.5% | $2.3M+17.2% | $2.0M+8.9% | $1.8M-91.2% | $20.5M-49.5% | $40.5M+904.1% | $4.0M-96.3% | $109.8M+545.3% | $17.0M+3.2% | $16.5M-47.3% | $31.3M | N/A | N/A | $14.5M+128.1% | $6.4M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
AXGN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.3%-1.5pp | 75.8%-0.8pp | 76.6%-1.9pp | 78.5%-3.5pp | 82.0%+1.2pp | 80.8%-3.0pp | 83.7%-0.9pp | 84.6%0.0pp | 84.6%+0.3pp | 84.3%+2.0pp | 82.3%+2.7pp | 79.5%+1.8pp | 77.7%+3.2pp | 74.5%+24.5pp | 50.0% |
| Operating Margin | -3.5%-1.7pp | -1.8%+11.8pp | -13.5%+7.9pp | -21.4%-1.5pp | -20.0%+0.7pp | -20.6%+8.8pp | -29.4%-5.0pp | -24.4%-11.3pp | -13.2%+6.6pp | -19.8%+14.1pp | -33.9%+24.4pp | -58.3%+29.3pp | -87.6% | -101.4% | -143.7% |
| Net Margin | -7.0%-1.7pp | -5.3%+8.3pp | -13.7%+7.2pp | -20.9%+0.3pp | -21.2%0.0pp | -21.2%+6.1pp | -27.3%-0.6pp | -26.7%-9.4pp | -17.3%+17.8pp | -35.1%+13.8pp | -48.9% | -105.3% | -133.0% | -122.4% | -190.1% |
| Return on Equity | -12.2%-2.6pp | -9.6%+13.1pp | -22.7%+6.0pp | -28.7%-4.7pp | -24.0%-4.7pp | -19.3%+2.7pp | -22.1%-6.8pp | -15.2%+26.2pp | -41.5%+55.1pp | -96.6%+66.4pp | -163.0% | N/A | -10654.0% | N/A | -151.8% |
| Return on Assets | -7.1%-2.2pp | -4.9%+6.1pp | -11.0%+3.8pp | -14.8%-1.8pp | -13.0%-1.2pp | -11.8%+7.0pp | -18.8%-4.9pp | -14.0%+3.8pp | -17.7%+13.3pp | -31.1%+5.3pp | -36.4%+71.6pp | -108.0%-55.4pp | -52.6%-6.0pp | -46.6%+27.2pp | -73.8% |
| Current Ratio | 5.11+1.9x | 3.24+0.3x | 2.89-1.2x | 4.13-1.1x | 5.23-1.1x | 6.36-0.1x | 6.47-5.1x | 11.57+7.5x | 4.06+0.1x | 3.97-5.5x | 9.45+3.6x | 5.89-6.3x | 12.23-0.1x | 12.36+7.0x | 5.39 |
| Debt-to-Equity | 0.38-0.1x | 0.460.0x | 0.490.0x | 0.45+0.1x | 0.40+0.1x | 0.26+0.3x | 0.000.0x | 0.00-0.8x | 0.79-0.6x | 1.36-1.7x | 3.01 | N/A | 185.63 | N/A | 0.73 |
| FCF Margin | -1.3%-2.1pp | 0.8%+13.1pp | -12.3%+13.8pp | -26.1%+6.3pp | -32.4%-4.3pp | -28.1%-5.1pp | -23.0%+5.8pp | -28.8%-11.6pp | -17.1%+12.5pp | -29.6%+19.7pp | -49.3%+16.1pp | -65.4%+31.7pp | -97.0% | -113.2% | -146.4% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Axogen Inc Ranks
Frequently Asked Questions
What is Axogen Inc's annual revenue?
Axogen Inc (AXGN) reported $225.2M in total revenue for fiscal year 2025. This represents a 20.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Axogen Inc's revenue growing?
Axogen Inc (AXGN) revenue grew by 20.2% year-over-year, from $187.3M to $225.2M in fiscal year 2025.
Is Axogen Inc profitable?
No, Axogen Inc (AXGN) reported a net income of -$15.7M in fiscal year 2025, with a net profit margin of -7.0%.
What is Axogen Inc's EBITDA?
Axogen Inc (AXGN) had EBITDA of -$1.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Axogen Inc have?
As of fiscal year 2025, Axogen Inc (AXGN) had $35.5M in cash and equivalents against $48.4M in long-term debt.
What is Axogen Inc's gross margin?
Axogen Inc (AXGN) had a gross margin of 74.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Axogen Inc's operating margin?
Axogen Inc (AXGN) had an operating margin of -3.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Axogen Inc's net profit margin?
Axogen Inc (AXGN) had a net profit margin of -7.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Axogen Inc's return on equity (ROE)?
Axogen Inc (AXGN) has a return on equity of -12.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Axogen Inc's free cash flow?
Axogen Inc (AXGN) recorded an outflow of $2.9M in free cash flow during fiscal year 2025. This represents a -304.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Axogen Inc's operating cash flow?
Axogen Inc (AXGN) generated $812K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Axogen Inc's total assets?
Axogen Inc (AXGN) had $221.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Axogen Inc's capital expenditures?
Axogen Inc (AXGN) invested $3.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Axogen Inc spend on research and development?
Axogen Inc (AXGN) invested $32.9M in research and development during fiscal year 2025.
What is Axogen Inc's current ratio?
Axogen Inc (AXGN) had a current ratio of 5.11 as of fiscal year 2025, which is generally considered healthy.
What is Axogen Inc's debt-to-equity ratio?
Axogen Inc (AXGN) had a debt-to-equity ratio of 0.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Axogen Inc's return on assets (ROA)?
Axogen Inc (AXGN) had a return on assets of -7.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Axogen Inc's Altman Z-Score?
Axogen Inc (AXGN) has an Altman Z-Score of 17.41, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Axogen Inc's Piotroski F-Score?
Axogen Inc (AXGN) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Axogen Inc's earnings high quality?
Axogen Inc (AXGN) reported a net loss of $15.7M while generating $812K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Axogen Inc cover its interest payments?
Axogen Inc (AXGN) reported an operating loss of $7.8M against $7.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Axogen Inc?
Axogen Inc (AXGN) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.